Skip to main content
Displaying 13 - 21 of 21
Display:
12
24
48
Liver Tumours
5
Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022
View
Liver Tumours
5
Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022
View
Liver Tumours
5
Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy